Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TP53BP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SBNO2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C1orf141 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | SLK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | NXNL2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GLYCTK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | RIC8A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NFE2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |